Month: June 2026

Phoenix, AZ, June 30, 2026 (GLOBE NEWSWIRE) — InnSuites Hospitality Trust (NYSE American: IHT) announced today that it received written notice from NYSE American LLC (“NYSE American”) on June 24, 2026, indicating that the Trust is not in compliance with the continued listing standard set forth in Section 1003(a)(i) of the NYSE American Company Guide.

Aptose Biosciences Announces Completion of Acquisition by Hanmi Pharmaceutical

New TEDx presentation offers a practical framework for identifying competing values and making choices with greater clarity and confidence

New TEDx presentation offers a practical framework for identifying competing values and making choices with greater clarity and confidence

Carbon Streaming Announces UpEnergy Default Under Community Carbon Stream Buyout Agreement

HAMPTON, N.H., June 30, 2026 (GLOBE NEWSWIRE) — Unitil Corporation (NYSE:UTL) (“Unitil” or the “Company”) (unitil.com) today announced that it completed the purchase of Aquarion Water Company of New Hampshire, Inc. and Abenaki Water Co., Inc. (the “Aquarion Companies”) from the Aquarion Water Authority (“AWA”). The Stock Purchase Agreement (the “Agreement”) between Unitil and the AWA was first announced on May 6, 2025 and subsequently amended, including to limit Unitil’s purchase to the two Aquarion Companies. All conditions of the Agreement, as amended, including the receipt of approvals from the New Hampshire and Maine Public Utilities Commissions, were materially completed as of the closing date.

Eversource Energy (NYSE:ES) (“Eversource”) today announced that it has successfully completed the sale of Aquarion Water Company (“AWC”).

expands its IP portfolio to clinical-stage biopharmaceutical assets

PHILADELPHIA, PA, June 30, 2026 (GLOBE NEWSWIRE) — Osprey Acquisition Corp. III (NASDAQ:OSPRU) (the “Company”) today announced the pricing of its initial public offering of 26,100,000 units at a price of $10.00 per unit. The Company’s units will be listed on the Nasdaq Global Market under the symbol “OSPRU” and will begin trading on July 1, 2026. Each unit issued in the offering consists of one Class A ordinary share of the Company and one-third of one redeemable warrant, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on NASDAQ under the symbols “OSPR” and “OSPRW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The closing of the offering is anticipated to take place on or about July 2, 2026, subject to customary closing conditions.

The company’s LTDF graphene is a substitute for the metals China controls, and the round drew $2.5 million in less than two weeks, shortly before a US-China minerals truce expires.

The company's LTDF graphene is a substitute for the metals China controls, and the round drew $2.5 million in less than two weeks, shortly before a US-China minerals truce expires.

New York, June 30, 2026 (GLOBE NEWSWIRE) —   Alpex Acquisition Corporation (the “Company”) (Nasdaq: ALPX), a blank check company, today announced that, commencing on July 7, 2026, holders of 11,500,000 units (the “Units”) sold in the Company’s initial public offering (the “Offering”), may elect to separately trade the Class A ordinary shares, warrants, and rights included in the Units. Any Units not separated will continue to trade on the NASDAQ Global Market (“NASDAQ”) under the symbol “ALPXU.” Any underlying Class A ordinary shares, warrants, and rights that are separated will trade on the NASDAQ under the symbols “ALPX,” “ALPXW,” and “ALPXR,” respectively. Holders of Units will need to have their brokers contact the Company’s transfer agent, VStock Transfer LLC, in order to separate the holders’ Units into Class A ordinary shares, warrants, and rights.

Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline

QUANZHOU, China, June 30, 2026 (GLOBE NEWSWIRE) — INLIF LIMITED (NASDAQ: INLF) (together with all its subsidiaries and consolidated entities, the “Company” or “INLIF”), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced that its Board of Directors has approved a 1-for-200 share combination of all its authorized and issued ordinary shares, including both Class A ordinary shares and Class B ordinary shares (the “Second Share Combination”), pursuant to the authorization granted from an extraordinary general meeting of the Company’s shareholders on January 9, 2026 (the “EGM”).

House of Doge (NASDAQ: HODO), the corporate arm of the Dogecoin Foundation, completes its merger with Brag House Holdings and begins trading on Nasdaq.

Adaptive ML will join Datadog’s AI lab to build frontier AI infrastructure to address cutting-edge research challenges within observability and security

Adaptive ML will join Datadog’s AI lab to build frontier AI infrastructure to address cutting-edge research challenges within observability and security